29/12/2009
Cell Therapeutics, Inc.
SEATTLE, Dec. 28 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that on December 24, 2009, CTI's Board of Directors (the "Board of Directors") rejected and dropped a Shareholder Rights Plan (the "Rights Plan") in which one preferred stock purchase right could be distributed for each common share held as of the close of business on January 7, 2010. Initially, the rights are exercisable, and are attached to and trade with, all of the shares of CTI's common stock outstanding as of, and issued subsequent to, the record date.
Subscribe to:
Post Comments (Atom)
SOUTH AFRICA SPRINGBOKS
South Africa laid the groundwork with traditional Springbok rugby and finished an out-gunned England side off with two late tries to win ...
-
The crude Saga continues with the price reaching the $117,60 a barrel...due to OPEP speculation and greed ... All OPEC members have shown th... -
WorldWatch chief analyst reports that once more Portugal places its bail-out plan in serious danger of not being able to carry out the auste... -
Oil rose to a one-week high in New York after OPEC failed to reach an agreement on production targets for the first time in at least 20 year...
No comments:
Post a Comment